Molecular biology of medulloblastoma therapy

Pediatric Neurosurgery

Volumn 39, Issue 6, 2003, Pages 299-304

  Pomeroy, Scott L ^a,b   Sturla, Lisa Marie ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

APC; Medulloblastoma; Neurotrophin; Patched; Risk stratification; Sonic hedgehog; Wnt

Indexed keywords

APC; CANCER GROWTH FACTOR; MOLECULAR MARKER; NEUROTROPHIN; SONIC HEDGEHOG PROTEIN; WNT1 PROTEIN;

ARTICLE; CARCINOGENESIS; DRUG DESIGN; DRUG TARGETING; EPIGENETICS; HUMAN; MEDULLOBLASTOMA; MOLECULAR BIOLOGY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SIGNAL TRANSDUCTION; TISSUE CULTURE; TISSUE PRESERVATION; TREATMENT PLANNING; TUMOR GROWTH;

BRAIN NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; GROWTH SUBSTANCES; HUMANS; MEDULLOBLASTOMA; RECEPTORS, GROWTH FACTOR; RISK ASSESSMENT; TUMOR MARKERS, BIOLOGICAL;

EID: 1642496855     PISSN: 10162291     EISSN: None     Source Type: Journal    
DOI: 10.1159/000075257     Document Type: Article

References (41)

1. Packer RJ, et al: Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 1994;81:690-698.
2. Louis DN, Pomeroy SL, Cairncross JG: Focus on central nervous system neoplasia. Cancer Cell 2002;1:125-128.
3. Biegel JA, et al: Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 1999;59:74-79.
4. Segal RA, et al: Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Proc Natl Acad Sci USA 1994;91:12867-12871.
5. Kim JY, et al: Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomas. Cancer Res 1999;59:711-719.
6. Pomeroy SL, et al: Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 2002;415:436-442.
7. Gilbertson RJ, et al: Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma. Cancer Res 1997;57:3272-3280.
8. Grotzer MA, et al: TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors. J Clin Oncol 2000;18:1027-1035.
9. Grotzer MA, et al: MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma. Clin Cancer Res 2001;7:2425-2433.
10. Thiesing JT, et al: Efficacy of STI571, an abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against bcr-abl-positive cells. Blood 2000;96:3195-3199.
11. McLaughlin M, et al: Marked regression of a metastatic pilocytic astrocytoma during treatment with imatinib mesylate (STI-571, Gleevec). J Pediatr Hematol Oncol, in press.
12. Johnson RL, et al: Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996;272:1668-1671.
13. Hahn H, et al: Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996;85:841-851.
14. Marigo V, et al: Biochemical evidence that patched is the Hedgehog receptor. Nature 1996;384:176-179.
15. Wechsler-Reya RJ, Scott MP: Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog. Neuron 1999;22:103-114.
16. Pietsch T, et al: Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. Cancer Res 1997;57:2085-2088.
17. Raffel C, et al: Sporadic medulloblastomas contain PTCH mutations. Cancer Res 1997;57:842-845.
18. Dong J, et al: Identification of PATCHED mutations in medulloblastomas by direct sequencing. Hum Mutat 2000;16:89-90.
19. Taylor MD, et al: Mutations in SUFU predispose to medulloblastoma. Nat Genet 2002;31:306-310.
20. Hamilton SR, et al: The molecular basis of Turcot's syndrome. N Engl J Med 1995;332:839-847.
21. Huang H, et al: APC mutations in sporadic medulloblastomas. Am J Pathol 2000;156:433-437.
22. Koch A, et al: Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors. Int J Cancer 2001;93:445-449.
23. Yokota N, et al: Role of Wnt pathway in medulloblastoma oncogenesis. Int J Cancer 2002;101:198-201.
24. Zurawel RH, et al: Sporadic medulloblastomas contain oncogenic beta-catenin mutations. Cancer Res 1998;58:896-899.
25. Taipale J, et al: Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature 2000;406:1005-1009.
26. Berman DM, et al: Medulloblastoma growth inhibition by hedgehog pathway blockade. Science 2002;297:1559-1561.
27. Willert J, et al: A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev Biol 2002;2:8.
28. Lawinger P, et al: The neuronal repressor REST/NRSF is an essential regulator in medulloblastoma cells. Nat Med 2000;6:826-831.
29. Fruhwald MC, et al: Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas - Implications for tumor biology and potential clinical utility. Oncogene 2001;20:5033-5042.
30. Lusher ME, et al: Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development. Cancer Res 2002;62:5906-5911.
31. Zuzak TJ, et al: Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour/medulloblastoma. Eur J Cancer 2002;38:83-91.
32. Rood BR, et al: Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma. Cancer Res 2002;62:3794-3797.
33. Segal RA, Pomeroy SL, Stiles CD: Axonal growth and fasciculation linked to differential expression of BDNF and NT3 receptors in developing cerebellar granule cells. J Neurosci 1995;15:4970-4981.
34. MacDonald TJ, et al: Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet 2001;29:143-152.
35. Gilbertson R, et al: Clinical and molecular stratification of disease risk in medulloblastoma. Br J Cancer 2001;85:705-712.
36. Hernan R, et al: ERBB2 up-regulates S100A4 and several other prometastatic genes in medulloblastoma. Cancer Res 2003;63:140-148.
37. Ambartsumian NS, et al: Metastasis of mammary carcinomas in GRS/A hybrid mice transgenic for the mts1 gene. Oncogene 1996;13:1621-1630.
38. Davies MP, et al: Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours. Oncogene 1996;13:1631-1637.
39. Del Valle L, et al: Insulin-like growth factor I receptor activity in human medulloblastomas. Clin Cancer Res 2002;8:1822-1830.
40. Eberhart CG, et al: Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas. Brain Pathol 2002;12:36-44.
41. Herms J, et al: c-myc expression in medulloblastoma and its prognostic value. Int J Cancer 2000;89:395-402.